The use of direct acting oral anticoagulants in patients with COVID-19 infection

The use of direct acting oral anticoagulants in patients with COVID-19 infection

The use of direct-acting oral anticoagulants (DOACs) has increased rapidly in the last decade; becoming the mainstay for both the prophylaxis and the treatment of venous thromboembolism in various situations including non-valvular atrial fibrillation, joint replacement surgeries and acute DVT/PE, et...

Full description

Bibliographic Details
Main Authors: Ragia Aly, Sachin Gupta, Balraj Singh, Parminder Kaur, Kunhwa Kim, Sorab Gupta
Format: Article
Language:English
Published: Greater Baltimore Medical Center 2021-03-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
covid 19
doac
dvt
Online Access:http://dx.doi.org/10.1080/20009666.2020.1867295

Similar Items

Similar Items